Evolving strategies in low-grade serous ovarian cancer: Applying the evidence to optimize patient care
touchEXPERT FOCUS for touchONCOLOGY
Listen to insights from Dr Kathleen Moore on the pathophysiology and molecular features of low-grade serous ovarian cancer (LGSOC) and how it differs from other ovarian cancers. She also discusses evidence-based treatment options and sequencing, as well as practical considerations relating to administration and side-effect management.
The expert:
Dr Kathleen Moore, OH Health Stephenson Cancer Center, Oklahoma City, OK, USA
This touchPODCAST is for HCPs in the USA only.
This activity is funded by an independent medical education grant from Verastem, Inc.
The…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.